24/7 Wall St. on MSN
Abbott Labs vs. Pfizer: Which discounted healthcare titan screens as the bigger value trap?
Quick ReadAbbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs a 7% yield with a ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug ...
Zai Lab (ZLAB) and Pfizer (PFE) announced a strategic collaboration for the novel antibacterial drug Xacduro in mainland China. Pfizer’s affiliated companies will be exclusively authorized to ...
Zai Lab and Pfizer Inc. are teaming up in China to fight the deadly carbapenem-resistant Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam). Through ...
GROTON, Conn. (WTNH) — Counterfeit Medicine is a growing global threat. At Pfizer, a dedicated team is leading the fight to stop these dangerous fakes. CT Buzz reporter Jillian Andrews visited ...
Detailed price information for Telescope Innovations Cp (TELIF) from The Globe and Mail including charting and trades.
Chinese biotech Zai Lab Limited (ZLAB) announced late Monday that Chinese regulators approved its antibody-drug conjugate Tivdak, developed with Pfizer (PFE) and Genmab (GMAB), as a late-line ...
At a time when funding is scarce and it seems like more local life science companies are laying off or moving out of California, there are still opportunities being built for San Diego’s biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results